Skip to main content

Riluzole Oral Suspension Shortage

Last Updated: September 15, 2025
Status: Current

Unavailable, Current:

Available, Current:

Tiglutik, Oral Suspension, 50 mg/10 mL (EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.))

NDC Code: 70726-0303-2
Availability: Unavailable
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Reason for shortage: Requirements related to complying with good manufacturing practices
Related Information: Next release not available at this time; Shortage per Manufacturer: Product manufacturing interrupted due to viscosity testing
Therapeutic category: Neurology
Initial posting date: January 26, 2024
Contact info: 610-937-6172

Teglutik, Oral Suspension, 5 mg/1 mL (EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.))

NDC Code: 70726-0305-1
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Therapeutic category: Neurology
Initial posting date: January 26, 2024
Contact info: 610-937-6172
Related info link: https://www.fda.gov/media/177206/download

Teglutik, Oral Suspension, 5 mg/1 mL (EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.))

NDC Code: 70726-0306-1
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Therapeutic category: Neurology
Initial posting date: January 26, 2024
Contact info: 610-937-6172
Related info link: https://www.fda.gov/media/185612/download?attachment

Teglutik, Oral Suspension, 5 mg/1 mL (EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.))

NDC Code: 70726-0304-1
Availability: Available
Status: Current
Date of update: September 15, 2025
Update type: Reverified
Therapeutic category: Neurology
Initial posting date: January 26, 2024
Contact info: 610-937-6172
Related info link: https://www.fda.gov/media/185611/download?attachment

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer